Innovative Ovulation Tracker: From Concept to FDA-Approval in Nine Months

Molecular biologist Amy Beckley named GenXYZ 2018 for MFB Fertility

Lisa Ryckman //January 18, 2018//

Innovative Ovulation Tracker: From Concept to FDA-Approval in Nine Months

Molecular biologist Amy Beckley named GenXYZ 2018 for MFB Fertility

Lisa Ryckman //January 18, 2018//

AMY BECKLEY, 37

OWNER, MFB FERTILITY, BOULDER

Molecular biologist Beckley’s own battle with infertility underlies her passion to help other women and inspired her crowdfunding campaign to create and market a new ovulation tracking device. After raising $40,000, Beckley went from concept to FDA-registered product in just nine months.

She also has launched a nonprofit arm of her company to donate a portion of the profits to educate women about fertility, help them conceive and provide resources for pregnant women.